Vivesto's earnings are forecast to decline at 23.4% per annum. EPS is expected to grow by 1.9% per annum.
Key information
-23.4%
Earnings growth rate
1.91%
EPS growth rate
Biotechs earnings growth
22.8%
Revenue growth rate
n/a
Future return on equity
-41.60%
Analyst coverage
Low
Last updated
26 May 2026
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
DB:OMA - Analysts future estimates and past financials data (SEK Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2028
N/A
-63
-62
-62
1
12/31/2027
N/A
-46
-46
-46
1
12/31/2026
N/A
-31
-30
-30
1
12/31/2025
N/A
-34
-44
-34
N/A
9/30/2025
N/A
-36
-41
-31
N/A
6/30/2025
N/A
-39
-50
-40
N/A
3/31/2025
N/A
-40
-39
-33
N/A
12/31/2024
N/A
-40
-47
-47
N/A
9/30/2024
7
-93
-46
-46
N/A
6/30/2024
7
-99
-54
-53
N/A
3/31/2024
7
-117
-62
-62
N/A
12/31/2023
7
-129
-69
-69
N/A
9/30/2023
2
-284
-88
-88
N/A
6/30/2023
3
-340
-92
-91
N/A
3/31/2023
3
-351
-89
-88
N/A
12/31/2022
3
-357
-86
-86
N/A
9/30/2022
13
-140
-105
-104
N/A
6/30/2022
24
-99
-107
-107
N/A
3/31/2022
29
-118
-134
-133
N/A
12/31/2021
29
-133
-180
-146
N/A
9/30/2021
-184
-348
-358
-324
N/A
6/30/2021
-195
-354
-378
-341
N/A
3/31/2021
-199
-376
-216
-178
N/A
12/31/2020
4
-210
-211
-205
N/A
10/31/2020
205
-59
-19
-11
N/A
7/31/2020
205
-24
-56
-47
N/A
4/30/2020
206
-11
-19
-7
N/A
1/31/2020
4
-196
-198
-187
N/A
10/31/2019
6
-167
N/A
-168
N/A
7/31/2019
9
-210
N/A
-134
N/A
4/30/2019
10
-201
N/A
-119
N/A
1/31/2019
14
-154
N/A
-104
N/A
10/31/2018
13
-153
N/A
-97
N/A
7/31/2018
13
-117
N/A
-103
N/A
4/30/2018
12
-118
N/A
-124
N/A
1/31/2018
10
-128
N/A
-124
N/A
10/31/2017
10
-139
N/A
-144
N/A
7/31/2017
8
-155
N/A
-134
N/A
4/30/2017
7
-160
N/A
-133
N/A
1/31/2017
7
-151
N/A
-145
N/A
10/31/2016
16
-137
N/A
-147
N/A
7/31/2016
19
-139
N/A
-142
N/A
4/30/2016
23
-142
N/A
-128
N/A
1/31/2016
26
-139
N/A
-112
N/A
10/31/2015
18
-141
N/A
-93
N/A
7/31/2015
19
-124
N/A
-101
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: OMA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: OMA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: OMA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: Insufficient data to determine if OMA's revenue is forecast to grow faster than the German market.
High Growth Revenue: OMA is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: OMA is forecast to be unprofitable in 3 years.
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/10 01:09
End of Day Share Price
2026/06/10 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vivesto AB is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.